NOLA-B Nolato AB (publ)
Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company offers catheter balloons; breathing bags; non-conductive sealing and damping silicone products; primary plastic packaging for medicines; and crimp and dropper bottles. It also provides thermal heating pads, gap fillers, and paste under the Compatherm brand; Autolys M products, deep well plates, microtubes, PCR/qPCR products, pipettes and slim-line pipette tips, vial HP, and quality grades under the TreffLab by Nolato; and electromagnetic compatibility (EMC) products, including Compashield molded and extruded electromagnetic interference (EMI) shielding gaskets, Trishield, and MIL SPEC EMI shielding products. In addition, the company offers laboratory products, such as boxes with integrated lids; containers with hinged lids; sampling and transport tubes; spoons and cups; disposable tubes and containers; test tubes and ergonomic caps; and containers, vials, and slide tubes with push on lids. Further, it provides injection molding of plastic and silicone, injection blow molding, scientific and ceramic injection molding, dip and compression molding, and micro molding; extrusion and silicone sponge extrusion technologies; thermal management; decoration and cutting technologies; cleanroom production; assembly solutions; design and virtual prototyping solutions; and tool manufacturing. It serves medical technology, pharmaceutical, consumer electronics, telecom, automotive, hygiene, and other industrial sectors. The company was formerly known as Nordiska Latexfabriken i Torekov AB and changed its name to Nolato AB (publ) in 1982. Nolato AB (publ) was founded in 1938 and is headquartered in Torekov, Sweden.…
Industry Peers
Medical DevicesKey Statistics
About Nolato (STO: NOLA-B)
›
Nolato (STO: NOLA-B) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 5,755 employees.
The shares were at 52.60 SEK on 19 November 2026, down 10.5% over 52 weeks. Its 52-week range is 44.80 SEK to 62.80 SEK: the price is 16.2% below the high and 17.4% above the low.
At a market capitalisation of 14.17B SEK, it trades at 21.1 times trailing earnings and 18.0 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a discount of 18% for NOLA-B. It pays a dividend yielding 3.21% (it pays out 68% of its earnings), against a median of 2.36% among the dividend payers in that peer group.
Nolato reports return on equity of 14.0%, an operating margin of 10.0% and revenue up 6.7% year over year.
Its debt exceeds its cash by 1.79B SEK, a debt-to-equity ratio of 0.26. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 2 analysts cover the stock; their mean price target of 65.50 SEK is 24.5% above the current price. The next earnings report is expected on 8 February 2027.